{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:58:42Z","timestamp":1782431922926,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmc.2021.116279","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T07:44:16Z","timestamp":1623915856000},"page":"116279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-957X","authenticated-orcid":false,"given":"Francesca","family":"Mancuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bmc.2021.116279_b0005","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.bmc.2021.116279_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"10.1016\/j.bmc.2021.116279_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.bmc.2021.116279_b0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin Ther Pat"},{"issue":"17","key":"10.1016\/j.bmc.2021.116279_b0025","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1016\/j.bmcl.2005.06.055","article-title":"Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides","volume":"15","author":"Nishimori","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"24","key":"10.1016\/j.bmc.2021.116279_b0030","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116279_b0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-94-007-7359-2_14","article-title":"Carbonic anhydrases and brain pH in the control of neuronal excitability","volume":"75","author":"Ruusuvuori","year":"2014","journal-title":"Sub-cellular biochemistry"},{"issue":"1","key":"10.1016\/j.bmc.2021.116279_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728214.2012.664132","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"17","author":"Supuran","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.bmc.2021.116279_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116279_b0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14728214.13.2.383","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"13","author":"Supuran","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.bmc.2021.116279_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bmc.2021.116279_b0060","first-page":"9419521","article-title":"Crystallography and Its Impact on Carbonic Anhydrase Research","volume":"2018","author":"Lomelino","year":"2018","journal-title":"Int J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2021.116279_b0065","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cmdc.201500596","article-title":"In Vivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents","volume":"11","author":"Bruno","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2021.116279_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2013.10.071","article-title":"Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors","volume":"71","author":"De Luca","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2021.116279_b0075","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cmdc.201000044","article-title":"Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors","volume":"5","author":"Gitto","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2021.116279_b0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","article-title":"Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"87","author":"Abo-Ashour","year":"2019","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.bmc.2021.116279_b0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"24","key":"10.1016\/j.bmc.2021.116279_b0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"issue":"14","key":"10.1016\/j.bmc.2021.116279_b0095","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2021.116279_b0100","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116279_b0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bioorg.2018.11.014","article-title":"SLC-0111 enaminone analogs, 3\/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX","volume":"83","author":"Eldehna","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2021.116279_b0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2021.116279_b0115","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bmc.2016.01.019","article-title":"Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111","volume":"24","author":"Lomelino","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116279_b0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J Exp Pharmacol"},{"issue":"10","key":"10.1016\/j.bmc.2021.116279_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10100412","article-title":"Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.bmc.2021.116279_b0130","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1021\/acs.jmedchem.7b00264","article-title":"Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides","volume":"60","author":"Bruno","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116279_b0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejmech.2015.07.049","article-title":"Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms","volume":"102","author":"Buemi","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2021.116279_b0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/acsmedchemlett.0c00062","article-title":"Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms","volume":"11","author":"Mancuso","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116279_b0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejmech.2018.11.073","article-title":"Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety","volume":"163","author":"Buemi","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2021.116279_b0150","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116279_b0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"issue":"6","key":"10.1016\/j.bmc.2021.116279_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061571","article-title":"The Crystal Structure of a hCA VII Variant Provides Insights into the Molecular Determinants Responsible for Its Catalytic Behavior","volume":"19","author":"Buonanno","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.bmc.2021.116279_b0165","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/nprot.2007.406","article-title":"Version 1.2 of the Crystallography and NMR system","volume":"2","author":"Brunger","year":"2007","journal-title":"Nat Protoc"},{"issue":"Pt 5","key":"10.1016\/j.bmc.2021.116279_b0170","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography & NMR system: A new software suite for macromolecular structure determination","volume":"54","author":"Brunger","year":"1998","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"3","key":"10.1016\/j.bmc.2021.116279_b0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"issue":"6580","key":"10.1016\/j.bmc.2021.116279_b0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2021.116279_b0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck - a Program to Check the Stereochemical Quality of Protein Structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallogr"},{"issue":"1","key":"10.1016\/j.bmc.2021.116279_b0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1093-3263(02)00123-7","article-title":"VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs","volume":"21","author":"Pedretti","year":"2002","journal-title":"J Mol Graph Model"},{"issue":"8","key":"10.1016\/j.bmc.2021.116279_b0195","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.bmcl.2012.02.081","article-title":"Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists","volume":"22","author":"Zulli","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmc.2021.116279_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000097","article-title":"Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies","volume":"353","author":"Qin","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"issue":"16","key":"10.1016\/j.bmc.2021.116279_b0205","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1021\/jm100639f","article-title":"Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands","volume":"53","author":"Moussa","year":"2010","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.bmc.2021.116279_b0210","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1021\/acs.jmedchem.0c00424","article-title":"Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist","volume":"63","author":"Moritz","year":"2020","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2021.116279_b0215","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.bmc.2008.05.003","article-title":"Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain","volume":"16","author":"Drizin","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2021.116279_b0220","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1021\/acs.jmedchem.7b01070","article-title":"Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase","volume":"60","author":"Akbar","year":"2017","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2021.116279_b0225","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2006.12.113","article-title":"Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions","volume":"17","author":"Innocenti","year":"2007","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:13:33Z","timestamp":1760836413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962100287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":45,"alternative-id":["S096808962100287X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116279","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116279"}}